Each year, the Carol Kulok Award for Compassion shines a light on the extraordinary individuals who bring empathy, humanity and hope to patients and families facing pancreatic cancer. In 2026, we are ...
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit shares new consensus statements for the diagnosis and ...
PanCAN Patient Services Case Manager Trishana Horton offers some suggestions for how to navigate conversations with loved ...
For months, David Herman experienced mild fatigue, gastrointestinal discomfort and some weight loss – symptoms he’d rationalize away due to his busy schedule as a dad, partner and school principal.
The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
In the coming year, more people than ever before are expected to be diagnosed with pancreatic cancer. And with a five-year survival rate that continues to hover at 13%, this cancer remains one of the ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...
Recently, representing PanCAN Patient Services as our manager of research and education communication, I joined a group of patient advocates and researchers in Cambridge, UK, for an annual symposium ...
The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...